Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

17 trials with published results (29%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.2%

3 terminated out of 58 trials

Success Rate

93.5%

+7.0% vs benchmark

Late-Stage Pipeline

41%

24 trials in Phase 3/4

Results Transparency

40%

17 of 43 completed with results

Key Signals

17 with results93% success

Data Visualizations

Phase Distribution

49Total
Not Applicable (10)
P 1 (3)
P 2 (12)
P 3 (16)
P 4 (8)

Trial Status

Completed43
Recruiting4
Unknown3
Terminated3
Active Not Recruiting2
Not Yet Recruiting2

Trial Success Rate

93.5%

Benchmark: 86.5%

Based on 43 completed trials

Clinical Trials (58)

Showing 20 of 20 trials
NCT06534502Phase 4Not Yet Recruiting

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

NCT04309812Not ApplicableActive Not RecruitingPrimary

Transcranial Direct Current to Treat Epilepsy at Home

NCT03689114Phase 4CompletedPrimary

Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)

NCT06590896Phase 2RecruitingPrimary

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

NCT06967012Phase 4RecruitingPrimary

A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures

NCT05015868Not ApplicableCompletedPrimary

Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies

NCT06550726Not ApplicableRecruitingPrimary

High-resolution Multi-parametric Magnetic Resonance Imaging for Focal Epilepsy

NCT05248269Not ApplicableActive Not Recruiting

Thermocoagulation in Drug Resistant Focal Epilepsy

NCT03054961CompletedPrimary

Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study

NCT03949478Phase 2Recruiting

Treating Postictal Symptoms Using Ibuprofen and Nifedipine

NCT06374966Not Yet RecruitingPrimary

Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy

NCT05273398Phase 4CompletedPrimary

Effects of Diazepam on RNS Detections

NCT01745952Not ApplicableCompletedPrimary

Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)

NCT00512317Phase 2CompletedPrimary

Open-label Extension to Protocol 1042-0600

NCT03446664Not ApplicableCompletedPrimary

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

NCT03200769Not ApplicableCompleted

Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy

NCT02635633Not ApplicableTerminatedPrimary

Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept

NCT03916848Not ApplicableUnknown

Novel Network Analysis of Intracranial Stereoelectroencephalography

NCT00351611Phase 4CompletedPrimary

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

NCT00437281Phase 1CompletedPrimary

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Scroll to load more

Research Network

Activity Timeline